Skip to main content
Elsevier

Journals in Infectious diseases and chemotherapy

  • Journal of Clinical Virology

    • ISSN: 1386-6532
    Journal of Clinical Virology is an international journal and is the Official journal of the Pan American Society for Clinical Virology and The European Society for Clinical Virology.Journal of Clinical Virology aims to publish papers and reviews on the clinical aspects of human virology. It publishes articles on diagnostical methods and virus-induced clinical conditions. The manuscripts should be clinically practical and relevant.Submissions on new technologies for viral diagnosis and monitoring are particularly welcomed.The journal publishes on topics that include:• new diagnostic technologies • nucleic acid amplification and serologic testing • targeted and metagenomic next-generation sequencing • emerging pandemic viral threats • respiratory viruses • transplant viruses • chronic viral infections • cancer-associated viruses • gastrointestinal viruses • central nervous system viruses • one health (excludes animal health)Journal of Clinical Virology does not accept submissions on single cases or case series. Please submit manuscripts of this type to IDcases. Journal of Clinical Virology also does not accept submissions on fundamental virology. Please submit manuscripts of this type to Virology.
    Subscriptions

  • Acta Tropica

    • ISSN: 0001-706X
    Acta Tropica is an international journal on infectious diseases that covers public health sciences, medical and veterinary entomology, and biomedical research with particular emphasis on topics relevant to human and animal health.Its scope includes the biology of pathogens and vectors, host-parasite relationships, mechanisms of pathogenicity, clinical disease and chemotherapy. We welcome contributions in basic or applied research in disciplines such as epidemiology, disease ecology, diagnostics, interventions and control, drug and insecticide resistance, mathematical modelling, public health and social sciences, climate change, parasite and vector taxonomy, biology, ecology and behaviour, host and parasite genomics, biochemistry, immunology, and vaccine testing.Contribution... may be in the form of original research papers, review articles, short communications, opinion articles, or letters to the Editors.Only manuscripts of high scientific significance and innovation will be considered for publication. Criteria for rejection without review:Out of scopeManuscripts of minimal international relevance, including regional reports and studies of local interestCase reportsParasite and vector control strategies at very early inconclusive laboratory stages of development. For vector control studies, field validation is requiredField studies not replicated at least over two yearsStudies dealing with natural products (e.g., plant extracts) not characterized from a chemical point of view.Ethical issues, including plagiarism, submission of the manuscript to multiple journals, and lack of ethical approval where needed.Important Guidelines for AcceptanceEditors and the Editorial Board of Acta Tropica provide the following guidelines to help authors prepare manuscripts of high quality that can be considered for publication. Maximize your chances of acceptance by making sure your manuscript:Matches the scientific scope of the journalFollows the instructions specified in Acta Tropica guide for authorsPresents results that significantly advance science including innovative new approachesMeets quality standards of presentation and literature citationDemonstrates potential health or biomedical impact.The above points are critical for the publication of original papers. Be aware Editors carefully evaluate initial manuscript submissions and only those meeting the above criteria will be forwarded to review. If reviewed favourably and the authors seriously address all concerns, then chances of acceptance are increased. Review and Opinion articles may be invited by the Editors in Chief or submitted by authors responding to a recognized need. Reviews are expected to carefully synthesize and discuss the literature and make recommendations to advance respective scientific fields. Reviews and Opinions submitted by authors without research experience on the topic covered by the manuscript will not be considered. Systematic reviews adhering to PRISMA guidelines and meta-analyses are welcome. For any inquiry about Reviews and Opinions please contact our Special Content Editor, Prof. John Beier.
    Subscriptions

  • International Journal of Antimicrobial Agents

    • ISSN: 0924-8579
    Official journal of the International Society of Antimicrobial ChemotherapyThe International Journal of Antimicrobial Agents provides comprehensive and up-to-date peer reviewed reference information on the physical, pharmacological, in vitro and clinical properties of individual antimicrobial agents (antiviral agents, antiparasitic agents, antibacterial agents, antifungal agents, etc.). In addition, the journal signals new trends and developments in the field through highly authoritative review articles on antimicrobial agents. Special attention is given to articles providing insight into the problems of antimicrobial resistance both in the hospital and in the community. Both solicited reviews by top experts in the mentioned fields and high-quality original research papers are published.Additional information on the ISAC and its activities can be found at the ISAC Web site at: https://www.isac.wor...
    Subscriptions

  • Tuberculosis

    • ISSN: 1472-9792
    Tuberculosis is a speciality journal focusing on basic experimental research on tuberculosis.Tubercu... aims to publish original research and reviews. It publishes articles on host response and immunology of tuberculosis and the molecular biology, genetics and physiology of the organism.Submissions on bacteriological, immunological and pathogenesis aspects of the disease are particularly welcomed.The journal publishes topics including:• Clinical Trials • Diagnostics • Antimicrobial resistance • Immunology • Leprosy • Microbiology, including microbial physiology • Molecular epidemiology • Non-tuberculous Mycobacteria • Pathogenesis & Pathology • Vaccine developmentTuberculo... discourages submissions with a meta-analytical focus (eg, articles based on searches of published articles in public electronic databases, especially where there is lack of evidence of the personal involvement of authors in the generation of such material).Tuberculos... does not accept case report submissions or clinical case studies. You can submit manuscripts of this type to the companion journals IDCases and Clinical Microbiology Newsletter.
    Subscriptions

  • Diagnostic Microbiology and Infectious Disease

    • ISSN: 0732-8893
    Diagnostic Microbiology and Infectious Disease provides up to date and extensive articles on clinical microbiology.Diagnos... Microbiology and Infectious Disease aims to publish latest developments in clinical microbiology and the diagnosis and treatment of infectious diseases. It publishes articles on studies in bacteriology, virology, mycology, parasitology, immunology related to infections, immunoserology.Submi... on new procedures, unusual cases, controversial issues, and important new literature. are particularly welcomed.The journal publishes topics including:Informed commentaries on new antibioticsRapid and cost-effective methods in the laboratoryInstructiv... case studies with emphasis on complex circumstancesInsight... editorials on important current issuesBook reviews that keep you up-to-date on recently published literatureLaboratory and clinical management of microbial diseasesEpidemiology and pathogenesis of infectionsAutomation in the diagnostic microbiology laboratoryAntibiotic susceptibility testing
    Subscriptions

  • Parasitology International

    • ISSN: 1383-5769
    The Official, International Journal of the Japanese Society of ParasitologyParasito... International provides a medium for rapid, carefully reviewed publications in the field of human and animal parasitology. Original papers, rapid communications, and original case reports from all geographical areas and covering all parasitological disciplines, including structure, immunology, cell biology, biochemistry, molecular biology, and systematics, may be submitted. Reviews on recent developments are invited regularly, but suggestions in this respect are welcome. Letters to the Editor commenting on any aspect of the Journal are also welcome.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center
    Subscriptions

  • Antiviral Research

    • ISSN: 0166-3542
    Antiviral Research aims to publish manuscripts in the field of prevention and treatment of viral diseases in humans and vertebrate animals, and encourages authors to the submit manuscripts describing the activity of well-defined chemical compounds for the treatment of viral diseases. The journal is an Official Publication of the International Society for Antiviral Research. The types of papers published in Antiviral Research includes original research reports, short communications, commentaries and invited review* articles on the control of viral infections in humans. The journal’s scope encompasses:antivira... drugs, antibodies and host-response modifiers, including their synthesis, in vitro and in vivo testing and mechanisms of action.identificatio... and validation of new drug targets;laboratory animal models of viral diseases for antiviral efficacy testing;evolution of drug-resistant viruses and the development of effective counter measures;pathogenesi... of viral diseases and mechanisms of viral evasion of host immune responses;assessment... of drug safety;new or improved vaccines against viral infections of humans; the prevention and treatment of viral diseases of vertebrate animals, and reports of the testing of veterinary vaccines in the target animal species. All papers must include a sufficiently detailed description of methods to permit other investigators to replicate the experiments. Authors reporting the antiviral effect of a novel small-molecule drug must reveal its chemical structure. Claims of in vitro or in vivo efficacy of a drug or vaccine must be supported by appropriate statistical analysis that must be clearly described in the manuscript.Antiviral Research journal does not publish reports on viral diseases of plants or of insects, crustaceans or other invertebrates. Studies of viral diseases of livestock and companion animals must be clearly related to the development of realistic therapies. Papers on veterinary vaccines should report findings in the target animal species.We discourage the submission of manuscripts reporting the antiviral activity of unpurified natural products, or of partially purified substances of natural origin for which a mechanism of action has not been determined. Manuscripts claiming an antiviral effect of homeopathic products or other highly diluted preparations, or which fail to clearly identify the biological ingredient or molecule responsible for the antiviral activity of an experimental therapy, will not be considered for publication. Articles describing antiseptics with broad-spectrum antimicrobial activity will not be accepted. We discourage the submission of in silico docking studies or other computer-based predictions of antiviral activity that are not supported by data from biological assays. Citations of reports that have not undergone peer review must include the note "[not peer-reviewed]."ISAR members Authors who are ISAR members are encouraged to contact ISAR after their paper has been accepted for publication in order to benefit from their published work being highlighted in ISAR postings on their social media platforms (further details on this will be given in the AVR acceptance letter). *Antiviral Research journal has started a new initiative to publish at least two thematic special issues per year, containing invited reviews in addition to the ad hoc invitations to experts in the areas within the scope of the journal.
    Subscriptions

  • American Journal of Infection Control

    • ISSN: 0196-6553
    The American Journal of Infection Control (AJIC) covers key topics and issues in infection control and epidemiology. Infection control professionals, including physicians, nurses, and epidemiologists, rely on AJIC for peer-reviewed articles covering clinical topics as well as original research. As the official publication of the Association for Professionals in Infection Control and Epidemiology (APIC). AJIC is the foremost resource on infection control, epidemiology, infectious diseases, quality management, occupational health, and disease prevention. AJIC also publishes infection control guidelines from APIC and the CDC. AJIC is included in Index Medicus and CINAHL.
    Subscriptions

  • Microbial Pathogenesis

    • ISSN: 0882-4010
    Microbial Pathogenesis publishes original contributions and reviews about the molecular and cellular mechanisms of infectious diseases. It covers microbiology, host-pathogen interaction and immunology related to infectious agents, including bacteria, fungi, viruses and protozoa. It also accepts papers in the field of clinical microbiology, with the exception of case reports.Research Areas Include:Pathogenesis... factorsHost susceptibility or resistanceImmune mechanismsIdentifica... cloning and sequencing of relevant genesGenetic studiesViruses, prokaryotic organisms and protozoaMicrobiotaSy... biology related to infectious diseasesTargets for vaccine design (pre-clinical studies)The journal aims for rapid publication of articles of high quality and significance in an international forum. Please note that reviews are only accepted upon editorial invitation.Short Communications have the following limits. The manuscript should ideally contain no more than 4-6 Figures/Tables and 4000 words, including the title page, all sections of the manuscript (including the references), and Figure/Table legends. The abstract should be limited to 200 words.Microbial Pathogenesis does not accept submissions that primarily consist of (a) bioinformatics or computational analysis of public genomic or transcriptomic databases, or (b) the testing and evaluation of previously uncharacterized natural product-based drug candidates. The journal does not publish purely bioinformatic or computational studies without substantial experimental validation. Please be aware that experimental validation is a mandatory requirement for all submissions.
    Subscriptions